PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity - Sanford Burnham Prebys
Paper of the Week

PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity

AuthorCommunications
Date

July 8, 2020